Retinopathy Stocks List

Retinopathy Stocks Recent News

Date Stock Title
May 17 IRIX IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript
May 17 OCGN DXC Technology Issues Weak Outlook, Joins Take-Two Interactive And Other Big Stocks Moving Lower In Friday's Pre-Market Session
May 16 KOD Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
May 16 OCGN Nayax Posts Weak Q1 Results, Joins GameStop, Iris Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 15 KOD Kodiak Sciences GAAP EPS of -$0.82 beats by $0.21
May 15 KOD Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results
May 15 IRIX Q1 2024 IRIDEX Corp Earnings Call
May 15 OCGN Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy
May 15 IRIX IRIDEX Corp (IRIX) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
May 15 OCGN Ocugen Inc (OCGN) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid ...
May 15 OCGN Q1 2024 Ocugen Inc Earnings Call
May 14 IRIX Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
May 14 IRIX IRIDEX GAAP EPS of -$0.21 misses by $0.09, revenue of $11.8M misses by $0.2M
May 14 IRIX Iridex Reports First Quarter 2024 Financial Results
May 14 OCGN Ocugen, Inc. (OCGN) Q1 2024 Earnings Call Transcript
May 14 OCGN Ocugen GAAP EPS of -$0.05 beats by $0.01, revenue of $1.01M
May 14 OCGN Ocugen Provides Business Update with First Quarter 2024 Financial Results
May 14 KOD Kodiak Sciences dosing subjects in Phase III trial of diabetic retinopathy drug
May 14 IRIX Even after rising 11% this past week, IRIDEX (NASDAQ:IRIX) shareholders are still down 59% over the past three years
May 13 KOD Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy
Retinopathy

Retinopathy is any damage to the retina of the eyes, which may cause vision impairment. Retinopathy often refers to retinal vascular disease, or damage to the retina caused by abnormal blood flow. Age-related macular degeneration is technically included under the umbrella term retinopathy but is often discussed as a separate entity. Retinopathy, or retinal vascular disease, can be broadly categorized into proliferative and non-proliferative types. Frequently, retinopathy is an ocular manifestation of systemic disease as seen in diabetes or hypertension. Diabetes is the most common cause of retinopathy in the U.S. as of 2008. Diabetic retinopathy is the leading cause of blindness in working-aged people. It accounts for about 5% of blindness worldwide and is designated a priority eye disease by the World Health Organization.

Browse All Tags